Skip to content

Comparison between the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intraarticular normal saline injection on pain, functional limitation and range of motion; in knee osteoarthritis patients

Comparison between the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intraarticular normal saline injection on pain, functional limitation and range of motion; in knee osteoarthritis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221111056470N1
Enrollment
50
Registered
2022-12-10
Start date
2022-11-16
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: The group that received 25% dextrose hyper-tonic intra-articularly under ultrasound guidance. Intervention 2: Control group: The group that received normal saline

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: aged 55 to75 years; both genders; knee radiography anterior standing view have been for the last one month; have symptoms of osteoarthritis include pain, limitation in knee range of motion , and knee joint dryness for at least a month without any extra-articular involvement.

Exclusion criteria

Exclusion criteria: Inflammatory and vascular collagen diseases such as lupus and suspected knee infection, patients with coagulation disorders, patients with active lumbosacral radiculopathy and severe deformity of the spine and lower limbs, peripheral and central nervous system disorders, pregnancy, diabetes, history of surgery on the knee, injection of steroid drugs in the last two months or intra-articular injection of hyaluronic acid in the last 12 months or replacement of the knee joint, use of opioid drugs, body mass index over 40

Design outcomes

Primary

MeasureTime frame
Pain scale. Timepoint: Just before the intervention & 2,4,8 weeks later. Method of measurement: Visual Analogue Scale,Western Ontario and McMaster Universities Arthritis Index (WOMAC).;Knee flexion degree. Timepoint: Just before the intervention & 2,4,8 weeks later. Method of measurement: goniometry.

Secondary

MeasureTime frame
Functional limitation. Timepoint: Just before the intervention & 2,4,8 weeks later. Method of measurement: Oxford knee score and Western Ontario and McMaster Universities Arthritis Index (WOMAC).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafiseh Birang

Shiraz University of Medical Sciences

nafis_bg@yahoo.com+98 31 3624 1170

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026